| Is your age between 2 yrs and 17 yrs? |
|
|
|
| Gender: Male or Female |
|
|
|
| Do you have any of these conditions: ATOPIC DERMATITIS or Eczema (Atopic Dermatitis) or Dermatitis, Atopic or Dermatitis or Dermatite Atopique or Eczéma (Dermatite Atopique) or Hand Derma...? |
|
|
|
| Do you have any of these conditions: ATOPIC DERMATITIS or Eczema or Dermatitis, Atopic or Dermatite Atopique or Eczema (Atopic Dermatitis) or Dermatitis or Hand Dermatitis or Eczema (Atop...? |
|
|
|
| Do you have any of these conditions: ATOPIC DERMATITIS or Eczema or Hand Dermatitis or Eczema (Atopic Dermatitis) or Eczéma (Dermatite Atopique) or Dermatite Atopique or Dermatitis, Atopi...? |
|
|
|
| Do you have any of these conditions: Eczema (Atopic Dermatitis - Pediatric) or ATOPIC DERMATITIS or Dermatite Atopique or Dermatitis, Atopic or Eczéma (Dermatite Atopique) or Eczema (Atop...? |
|
|
|
| Do you have any of these conditions: Dermatitis or Eczema (Atopic Dermatitis) or Eczema (Atopic Dermatitis - Pediatric) or Dermatitis, Atopic or Eczema or Hand Dermatitis or Eczéma (Derma...? |
|
|
|
| Do you have any of these conditions: Eczema (Atopic Dermatitis - Pediatric) or Dermatite Atopique or Dermatitis or Hand Dermatitis or Dermatitis, Atopic or Eczema (Atopic Dermatitis) or E...? |
|
|
|
| Do you have any of these conditions: Dermatitis or Eczema (Atopic Dermatitis) or Eczema (Atopic Dermatitis - Pediatric) or Eczéma (Dermatite Atopique) or Dermatite Atopique or ATOPIC DERM...? |
|
|
|
| Do you have any of these conditions: Dermatitis, Atopic or Eczema (Atopic Dermatitis - Pediatric) or Eczema or Hand Dermatitis or Dermatitis or ATOPIC DERMATITIS or Eczema (Atopic Dermati...? |
|
|
|
| Do you have any of these conditions: Dermatitis or Eczema (Atopic Dermatitis) or Eczéma (Dermatite Atopique) or Eczema or Dermatitis, Atopic or ATOPIC DERMATITIS or Hand Dermatitis or Ecz...? |
|
|
|
| Do you have any of these conditions: ATOPIC DERMATITIS or Eczema or Hand Dermatitis or Eczema (Atopic Dermatitis) or Eczema (Atopic Dermatitis - Pediatric) or Eczéma (Dermatite Atopique) ...? |
|
|
|
| At or above the 5th percentile of weight for age |
|
|
|
| Have been diagnosed with moderate to severe atopic dermatitis for at least 12 months (if 6 years old or older) or at least 6 months (if 2 up to 6 years old) |
|
|
|
| Have had inadequate response or intolerance to existing topical (applied to the skin) medications within 6 months preceding screening |
|
|
|
| Are willing to discontinue certain treatments for eczema (such as systemic and topical treatments during a washout period) |
|
|
|
| Agree to use emollients daily |
|
|
|
| Are currently experiencing or have a history of other concomitant skin conditions (e.g., psoriasis or lupus erythematosus), or a history of erythrodermic, refractory, or unstable skin disease that requires frequent hospitalizations and/or intravenous treatment for skin infections |
|
|
|
| A history of eczema herpeticum within 12 months, and/or a history of 2 or more episode of eczema herpeticum in the past |
|
|
|
| Participants who are currently experiencing a skin infection that requires treatment, or is currently being treated, with topical or systemic antibiotics |
|
|
|
| Have any serious illness that is anticipated to require the use of systemic corticosteroids or otherwise interfere with study participation or require active frequent monitoring (e.g., unstable chronic asthma) |
|
|
|
| Have been treated with the following therapies |
|
|
|
| Monoclonal antibody for less than 5 half-lives prior to beginning study treatment |
|
|
|
| Received prior treatment with any oral Janus kinase (JAK) inhibitor |
|
|
|
| Received any parenteral corticosteroids administered by intramuscular or intravenous (IV) injection within 2 weeks prior to study entry or within 6 weeks prior to planned initiation of study drug or are anticipated to require parenteral injection of corticosteroids during the study |
|
|
|
| Have had an intra-articular corticosteroid injection within 2 weeks prior to study entry or within 6 weeks prior to planned initiation of study drug |
|
|
|
| Have high blood pressure characterized by a repeated systolic or diastolic blood pressure >95th percentile based on age, sex and height |
|
|
|
| Have had major surgery within the past eight weeks or are planning major surgery during the study |
|
|
|
| Have experienced any of the following within 12 weeks of screening: venous thromboembolic event (VTE), myocardial infarction (MI), unstable ischemic heart disease, stroke, or New York Heart Association Stage III/IV heart failure |
|
|
|
| Have a history of VTE or are considered at high risk of VTE as deemed by the investigator |
|
|
|
| Have a history or presence of cardiovascular, respiratory, hepatic, chronic liver disease gastrointestinal, endocrine, hematological, neurological, lymphoproliferative disease or neuropsychiatric disorders or any other serious and/or unstable illness |
|
|
|
| Have a current or recent clinically serious viral, bacterial, fungal, or parasitic infection including herpes zoster (shingles or chicken pox), tuberculosis |
|
|
|
| Have specific laboratory abnormalities |
|
|
|
| Have received certain treatments that are contraindicated |
|
|
|
| Pregnant or breastfeeding |
|
|
|
